Goodwill of ProPhase Labs, Inc. from 23 Oct 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
ProPhase Labs, Inc. quarterly Goodwill in USD history and change rate from 23 Oct 2020 to 30 Sep 2025.
  • ProPhase Labs, Inc. Goodwill for the quarter ending 30 Sep 2025 was $3,968,000, a 24% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

ProPhase Labs, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,968,000 -$1,263,000 -24% 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $5,231,000 $0 0% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $5,231,000 $0 0% 31 Mar 2025 10-Q 20 May 2025 2025 Q1
Q4 2024 $5,231,000 $0 0% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 $5,231,000 $0 0% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $5,231,000 $0 0% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $5,231,000 $0 0% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $5,231,000 -$478,000 -8.4% 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 $5,231,000 -$478,000 -8.4% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $5,231,000 -$478,000 -8.4% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $5,231,000 -$478,000 -8.4% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $5,709,000 $0 0% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $5,709,000 +$4,324,000 +312% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $5,709,000 +$4,808,000 +534% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $5,709,000 +$4,808,000 +534% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $5,709,000 +$4,808,000 +534% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $1,385,000 +$484,000 +54% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $901,000 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $901,000 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $901,000 31 Dec 2020 10-K 29 Mar 2023 2022 FY
Q3 2020 $901,000 23 Oct 2020 10-Q 13 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.